Cargando…
Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
BACKGROUND: Forkhead box transcription factor 1 (FOXM1) has been reported to overexpress and correlate with pathogenesis in a variety of human malignancies. However, little research has been done to investigate its clinical significance in gastric cancer. METHODS: We examined the expression of FOXM1...
Autores principales: | Li, Xiaoxiao, Qiu, Wensheng, Liu, Bin, Yao, Ruyong, Liu, Shihai, Yao, Yasai, Liang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766246/ https://www.ncbi.nlm.nih.gov/pubmed/24004449 http://dx.doi.org/10.1186/1479-5876-11-204 |
Ejemplares similares
-
FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin
por: Li, Xiaoxiao, et al.
Publicado: (2014) -
High expression of forkhead box M1 (FOXM1) is a poor prognostic biomarker in lung adenocarcinoma
por: Xiao, Hong, et al.
Publicado: (2020) -
Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
por: Ito, Takamichi, et al.
Publicado: (2016) -
Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
por: Tabnak, Peyman, et al.
Publicado: (2023) -
Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
por: Zhao, Fung, et al.
Publicado: (2014)